US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
AMEX
NovaBay Pharmaceuticals Inc New (NBY)
NovaBay Pharmaceuticals Inc New (NBY) ニュース

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:NBY

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	21 : 30	Business Wire	NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/05/10	05 : 05	Business Wire	NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/05/07	21 : 00	Business Wire	NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/05/03	19 : 50	Business Wire	NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/04/22	19 : 57	Business Wire	NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/04/20	07 : 00	Business Wire	NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/04/17	19 : 59	Business Wire	NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/03/27	05 : 05	Business Wire	NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/03/26	07 : 38	Business Wire	NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/03/14	21 : 00	Business Wire	NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/02/15	04 : 52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/02/07	01 : 52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/01/30	23 : 00	Business Wire	NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/01/10	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/01/09	23 : 15	Business Wire	NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2024/01/05	01 : 50	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/12/21	21 : 58	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/12/12	06 : 32	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/12/06	20 : 50	Business Wire	NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/11/10	06 : 05	Business Wire	NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/11/02	19 : 50	Business Wire	NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/10/11	21 : 00	Business Wire	NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/10/02	19 : 50	Business Wire	NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/09/21	22 : 35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/09/14	21 : 00	Business Wire	NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/09/11	21 : 00	Business Wire	NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/08/11	05 : 47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/08/11	05 : 05	Business Wire	NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results	AMEX:NBY	NovaBay Pharmaceuticals Inc New
2023/08/09	05 : 05	Business Wire	NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023	AMEX:NBY	NovaBay Pharmaceuticals Inc New

Showing the most relevant articles for your search:AMEX:NBY

1 2 3 4 5 6 7 8 9 10 次へ >>

Societe Generale Effekten

Wind Works Power (CE)

TheCurrencyAnalytics

Lulus Fashion Lounge

Gladstone Acquisition

Caliber Imaging and Diag... (CE)

Biotech Acquisition

Amplitude Surgical

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約